Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of βig-h3, via αvβ3 integrin

Cancer Research

Volumn 65, Issue 10, 2005, Pages 4153-4161

  Nam, Ju Ock ^a   Jeong, Ha Won ^a   Lee, Byung Heon ^a   Park, Rang Woon ^a   Kim, In San ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FASCILIN 1; FASTATIN; FIBRONECTIN; MAMMALIAN TARGET OF RAPAMYCIN; MATRIGEL; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BETAIG H3; PROTEIN KINASE B; RAF PROTEIN; REGULATOR PROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG; VITRONECTIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE CONTROL; HUMAN; HUMAN CELL; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTEGRIN ALPHAVBETA3; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 20144384004     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2705     Document Type: Article

References (30)

1. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of β ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 1992;11:511-22.
2. Skonier J, Bennett K, Rothwell V, et al. βig-h3: a transforming growth factor-β-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994;13:571-84.
3. Kim JE, Kim EH, Han EH, et al. A TGF-β-inducible cell adhesion molecule, βig-h3, is downregulated in melorheostosis and involved in osteogenesis. J Cell Biochem 2000;77:169-78.
4. Bae JS, Lee SH, Kim JE, et al. βig-h3 supports keratinocyte adhesion, migration, and proliferation through α3β1 integrin. Biochem Biophys Res Commun 2002;294:940-8.
5. Kim JE, Kim SJ, Jeong HW, et al. RGD peptides released from β ig-h3, a TGF-β-induced cell-adhesive molecule, mediate apoptosis. Oncogene 2003;22:2045-53.
6. Munier FL, Korvatska E, Djemai A, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247-51.
7. O'Brien ER, Bennett KL, Garvin MR, et al. βig-h3, a transforming growth factor-β-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 1996; 16:576-84.
8. Lee SH, Bae JS, Park SH, et al. Expression of TGF-β-induced matrix protein βig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int 2003;64:1012-21.
9. Park SW, Bae JS, Kim KS, et al. βig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with α3β1 integrin. Exp Mol Med 2004;36:211-9.
10. Kawamoto T, Noshiro M, Shen M, et al. Structural and phylogenetic analyses of RGD-CAP/βig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes. Biochim Biophys Acta 1998;1395:288-92.
11. Kim JE, Kim SJ, Lee BH, Park RW, Kim KS, Kim IS. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-β-induced gene, βig-h3. J Biol Chem 2000;275:30907-15.
12. Kim JE, Jeong HW, Nam JO, et al. Identification of motifs in the fasciclin domains of the transforming growth factor-β-induced matrix protein βig-h3 that interact with the αvβ5 integrin. J Biol Chem 2002; 277:46159-65.
13. Nam JO, Kim JE, Jeong HW, et al. Identification of the αvβ3 integrin-interacting motif of βig-h3 and its anti-angiogenic effect. J Biol Chem 2003;278:25902-9.
14. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins. Proc Natl Acad Sci U S A 2003;100:4766-71.
15. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984;67:379-88.
16. Kwon KB, Park EK, Ryu DG, Park BH. D4-GD1 is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp Mol Med 2002;34:32-7.
17. Kunath K, Merdan T, Hegener O, Haberlein H, Kissel T. Integrin targeting using RGD PEI conjugates for in vitro gene transfer. J Gene Med 2003;5:558-99.
18. Hamada JI, Omatsu T, Okada F, et al. Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 2001;93:516-25.
19. Maeshima Y, Sudhakar A, Lively JC, et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002;295:140-3.
20. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-64.
21. Maeshima Y, Yerramalla UL, Dhanabal M, et al. Extracellular matrix-derived peptide binds to α(v)β(3) integrin and inhibits angiogenesis. J Biol Chem 2001;276:31959-68.
22. Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA. Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol 2003;162:933-43.
23. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999;18:882-92.
24. Borges E, Jan Y, Ruoslahti E. Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β 3 integrin through its extracellular domain. J Biol Chem 2000; 275:39867-73.
25. Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 2001;92:843-8.
26. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
27. Zhou B, Weigel JA, Saxena A, Weigel PH. Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis. Mol Biol Cell 2002;13:2853-68.
28. Adachi H, Tsujimoto M. FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. J Biol Chem 2002;277: 34264-70.
29. Bocci G, Francia G, Man S, Lawler J, Kerbel RS. Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci U S A 2003;100:12917-22.
30. Dhar DK, Ono T, Yamanoi A, et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 2002;95:2188-95.